Do I Qualify?
Noura Abul-Husn's avatarPerson

Noura Abul-Husn

Vice President of Genomic Health23andMe

Sunnyvale, CA

Member Since July 2023


Personalized Health
Precision Health


I am an effective, results-driven leader and expert in genomic medicine and personalized healthcare. As a physician scientist who thrives on innovation, my career has taken a non-linear path bridging the intricate world of academia and the dynamic realm of industry. I am skilled at approaching problems with a clinical and business lens and managing multidisciplinary teams through times of rapid evolution. I have led high-impact clinical, educational, and research programs to extend the reach of genomic medicine. My scientific contributions include pioneering genome-first approaches to generate novel clinical insights, power therapeutic discovery, and inform population health. My work has been published in leading scientific journals and has been recognized with numerous awards and honors. With an unwavering commitment to health equity and a vision of a future where genomic medicine benefits all, I am dedicated to advancing personalized healthcare and driving transformative change at the intersection of genomics and health.

Published content

Five things entrepreneurs can learn from a physician-scientist


Here are five things I learned while seeing patients and conducting research that have helped me and can help other business leaders.

Company details


Company bio

23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. 23andMe was named as one of the San Francisco Chronicle's Top Workplaces and one of Comparably's Best Places to Work in 2022. CEO, Anne Wojcicki was also named one of Glassdoor’s top CEOs in 2019 and one of Comparably’s "Best CEOs for Women" in 2021 and 2022. More information is available at



Area of focus

genetic research
consumer genetics
direct-to-consumer genetic testing

Company size

501 - 1,000